{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OW-2006-0771-1800", "EPA", "EPA-HQ-OW-2006-0771", "Letter to Mark J. Shultz, President, Pharmaceutical Services, Inc.  - DCN 06093", "Supporting & Related Material", "Letter, Memorandum, Email", "2008-09-17T04:00:00Z", 2008, 9, null, null, "2008-09-17T19:28:12Z", null, 0, 0, "09000064806f7035"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OW-2006-0771-1800"], "units": {}, "query_ms": 24.300594988744706, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}